Nephrology - Global Kidney Academy

17-32 of 88

Gabapentinoids: Safety Considerations and Downstream Outcomes
Gabapentinoids: Safety Considerations and Downstream Outcomes
MinuteCE®
Gabapentinoids: Safety Considerations and Downstream Outcomes
Federico Alberici, MD, PhD; Anastasia Liossatou, PhD, RN
1.00 program credit
- Federico Alberici, MD, PhD
- Anastasia Liossatou, PhD, RN
1.00 program credit
What You Don’t See: A Patient’s View of Living with CKD-aP
What You Don’t See: A Patient’s View of Living with CKD-aP
MinuteCE®
What You Don’t See: A Patient’s View of Living with CKD-aP
Steven Fishbane, MD; Nancy Helou, PhD
1.00 program credit
- Steven Fishbane, MD
- Nancy Helou, PhD
1.00 program credit
Spotlight on Assessment: Tools That Capture CKD-aP
Spotlight on Assessment: Tools That Capture CKD-aP
MinuteCE®
Spotlight on Assessment: Tools That Capture CKD-aP
Federico Alberici, MD, PhD; Anastasia Liossatou, PhD, RN
1.00 program credit
- Federico Alberici, MD, PhD
- Anastasia Liossatou, PhD, RN
1.00 program credit
Reading Between the Lines: What PROMs Reveal About Itch
Reading Between the Lines: What PROMs Reveal About Itch
MinuteCE®
Reading Between the Lines: What PROMs Reveal About Itch
Federico Alberici, MD, PhD; Anastasia Liossatou, PhD, RN
1.00 program credit
- Federico Alberici, MD, PhD
- Anastasia Liossatou, PhD, RN
1.00 program credit
Translating the Latest KDIGO Guidelines Into Practice: IV Iron Therapy in Patients With Non–Dialysis-Dependent CKD
Translating the Latest KDIGO Guidelines Into Practice: IV Iron Therapy in Patients With Non–Dialysis-Dependent CKD
CME/CE
Translating the Latest KDIGO Guidelines Into Practice: IV Iron Therapy in Patients With Non–Dialysis-Dependent CKD
Patrick Rossignol, MD, PhD; Julio Núñez, MD, PhD
0.25 credits
- Patrick Rossignol, MD, PhD
- Julio Núñez, MD, PhD
0.25 credits
Optimizing Iron Deficiency Management in CKD: IV Iron Replacement Therapy Amid the Latest KDIGO Guidelines
Optimizing Iron Deficiency Management in CKD: IV Iron Replacement Therapy Amid the Latest KDIGO Guidelines
Nephrology
Optimizing Iron Deficiency Management in CKD: IV Iron Replacement Therapy Amid the Latest KDIGO Guidelines
Brendon Neuen, MBBS, PhD
- Brendon Neuen, MBBS, PhD
Navigating KDIGO Practice Guideline Recommendations to Maximize Proteinuria Reduction in Patients With IgAN
Navigating KDIGO Practice Guideline Recommendations to Maximize Proteinuria Reduction in Patients With IgAN
CME/CE
Navigating KDIGO Practice Guideline Recommendations to Maximize Proteinuria Reduction in Patients With IgAN
Chee Kay Cheung, MBChB, MRCP, PhD; Claudia Seikrit, MD
0.25 credits
- Chee Kay Cheung, MBChB, MRCP, PhD
- Claudia Seikrit, MD
0.25 credits
Vous prescrivez uniquement des antihistaminiques pour traiter les patients atteints de Pa-MRC ? Il est temps de revoir votre approche !
Vous prescrivez uniquement des antihistaminiques pour traiter les patients atteints de Pa-MRC ? Il est temps de revoir votre approche !
CME/CE
Vous prescrivez uniquement des antihistaminiques pour traiter les patients atteints de Pa-MRC ? Il est temps de revoir votre approche !
Antoine Lanot, MD, PhD; Gil Yosipovitch, MD
0.25 credits
- Antoine Lanot, MD, PhD
- Gil Yosipovitch, MD
0.25 credits
Stuck on Antihistamines for Managing Patients With CKD-aP? Time to Reconsider!
Stuck on Antihistamines for Managing Patients With CKD-aP? Time to Reconsider!
CME/CE
Stuck on Antihistamines for Managing Patients With CKD-aP? Time to Reconsider!
Antoine Lanot, MD, PhD; Gil Yosipovitch, MD
0.25 credits
- Antoine Lanot, MD, PhD
- Gil Yosipovitch, MD
0.25 credits
Inside the IgAN Clinic: Shared Decision-Making Into Practice
Inside the IgAN Clinic: Shared Decision-Making Into Practice
CME/CE
Inside the IgAN Clinic: Shared Decision-Making Into Practice
Jonathan Barratt, MD, PhD
0.25 credits
- Jonathan Barratt, MD, PhD
0.25 credits
Case-Based Approach: Managing Hyperkalemia in Patients With CKD and Heart Failure
Case-Based Approach: Managing Hyperkalemia in Patients With CKD and Heart Failure
CME/CE
Case-Based Approach: Managing Hyperkalemia in Patients With CKD and Heart Failure
Ellie Kelepouris, MD, FACP, FAHA; Nihar R. Desai, MD, MPH
0.25 credits
- Ellie Kelepouris, MD, FACP, FAHA
- Nihar R. Desai, MD, MPH
0.25 credits
Targeting CKD-aP at the Source: Key Mechanisms and Treatments
Targeting CKD-aP at the Source: Key Mechanisms and Treatments
CME/CE
Targeting CKD-aP at the Source: Key Mechanisms and Treatments
Steven Fishbane, MD; Maurizio Gallieni, MD
0.25 credits
- Steven Fishbane, MD
- Maurizio Gallieni, MD
0.25 credits
Individualized Management of Hyperkalemia: The Role of Potassium Binders in Patients With Cardiorenal Disease
Individualized Management of Hyperkalemia: The Role of Potassium Binders in Patients With Cardiorenal Disease
Nephrology
Individualized Management of Hyperkalemia: The Role of Potassium Binders in Patients With Cardiorenal Disease
Ellie Kelepouris, MD, FACP, FAHA
- Ellie Kelepouris, MD, FACP, FAHA
CKD-aP or Something Else? Decoding the Diagnosis
CKD-aP or Something Else? Decoding the Diagnosis
MinuteCE®
CKD-aP or Something Else? Decoding the Diagnosis
James Burton, DM, FRCP; Emilio Sanchez, MD, PhD
1.00 program credit
- James Burton, DM, FRCP
- Emilio Sanchez, MD, PhD
1.00 program credit
MinuteCE®
Decoding Itch in CKD: From CKD-aP Suspicion to Solution
James Burton, DM, FRCP; Leonie Kraft, MD
1.00 credit 9 episodes
- James Burton, DM, FRCP
- Leonie Kraft, MD
- Lucio Manenti, MD, PhD
- Emilio Sanchez, MD, PhD
1.00 credit 9 episodes
CKD-aP Treatment Tool Kit 
CKD-aP Treatment Tool Kit 
MinuteCE®
CKD-aP Treatment Tool Kit 
Leonie Kraft, MD; Emilio Sanchez, MD, PhD
1.00 program credit
- Leonie Kraft, MD
- Emilio Sanchez, MD, PhD
1.00 program credit

2/6